Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products
Dupixent peak sales ambition raised to more than €13 billion
The companies are now preparing to initiate a Phase 1 trial to assess the safety and immunogenicity of BLB-201 in healthy volunteers
As a partner with IRIA, the company had a significant booth presence on-ground during the conference.
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
Registration is open for the global event that invites technology enthusiasts to bring innovative ideas to improve healthcare outcomes
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
